Dissemin is shutting down on January 1st, 2025

Published in

American Medical Association, Jama Network Open, 5(6), p. e2316089, 2023

DOI: 10.1001/jamanetworkopen.2023.16089

Links

Tools

Export citation

Search in Google Scholar

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US

Journal article published in 2023 by Scott G. Weiner, Dima M. Qato ORCID, Jeremy Samuel Faust, Brian Clear
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

This cross-sectional study assesses the availability of buprenorphine for opioid use disorder treatment at local pharmacies in the US by state and retail pharmacy chain.